Biomedical Data Translator
NCATS’ Biomedical Data Translator program aims to accelerate biomedical translation by developing a biomedical “data translator” for the research community. Through this program, NCATS will integrate multiple types of existing data sources and reveal potential relationships across the spectrum of data types. For more information, send an email to firstname.lastname@example.org.
Bridging Interventional Development Gaps (BrIDGs)
Through its BrIDGs program, NCATS assists researchers in advancing promising therapeutic agents through late-stage pre-clinical development toward an Investigational New Drug application and clinical testing. NCATS is accepting proposals on an ongoing basis to collaborate with BrIDGs scientists. For more information, contact BrIDGs@mail.nih.gov.
Licensing, Technology Transfer & Patents
NCATS’ strategic alliances team helps industry and academic researchers interact and partner with Center laboratories and scientists. The Center’s support for technology development and partnership includes day-to-day negotiations of transactional agreements and licenses between NCATS and outside parties, including universities, pharmaceutical companies and biotechnology companies. For more information, email NCATSPartnerships@mail.nih.gov.
NCATS Chemical Genomics Center (NCGC)
NCATS’ NCGC program staff offer biomedical researchers access to large-scale screening capacity and medicinal chemistry and informatics expertise to develop chemical probe molecules. These resources can help scientists study the functions of genes, cells and biochemical pathways. The program also features assay development and high-throughput screening, chemistry and chemistry technology, automation, and informatics. To learn more and to obtain NCGC probe molecules, contact Juan Marugan.
NIH RNA Interference (RNAi) Initiative
Pfizer's Centers for Therapeutic Innovation (CTI) for NIH Researchers
NCATS is facilitating Pfizer's CTI program at NIH, which pairs NIH intramural researchers and clinicians with Pfizer resources to pursue scientific and medical advances through joint therapeutic development of biological compounds. Interested researchers can submit applications to their respective Technology Transfer Office (TTO) by October 13, 2017. For more information, contact NIH-PfizerCTI@mail.nih.gov.
Stem Cell Translation Laboratory (SCTL)
Through the new SCTL, NCATS will provide researchers across various disciplines and organizations with the ability to establish collaborations to advance the translation of regenerative medicine applications. NCATS seeks stem cell research collaborators from the biotechnology, pharmaceutical, and NIH intramural and extramural communities on an ongoing basis. Proposal receipt dates are July 1, November 1 and March 1. To learn more, contact Ilyas Singeç, M.D., Ph.D.
Therapeutics for Rare and Neglected Diseases (TRND)
The TRND program provides collaborators with access to significant in-kind resources and expertise to develop new therapeutics for rare and neglected diseases. NCATS is accepting proposals on an ongoing basis through the TRND program for collaborative projects that focus on pre-clinical and early clinical development of new drugs for rare and neglected tropical diseases. Email TRND@mail.nih.gov to learn more.
Toxicology in the 21st Century (Tox21)
The goal of the Tox21 program is to test 10,000 chemicals and evaluate their potential to cause health problems. Any investigator may propose the development of biological assays for high-throughput screening. Proposed assays must be compatible with the high-throughput screening guidelines described in the assay guidance criteria. To suggest an assay, submit a nomination form (PDF - 44KB) to Menghang Xia, Ph.D.
Collaborate on Other Intramural Projects
Explore other potential project collaborations with NCATS scientists by visiting the NIH Intramural Database and selecting “NCATS - National Center for Advancing Translational Sciences” in the “Select IC or Center” drop-down menu.